N. Kuhnly

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.

M. S. Merrill, E. Winer, E. Cerami, 2019, JCO precision oncology.